Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World August 23, 2013 Jessica Cocker	Plant protein regulates diabetes treatment A plant protein has been used to make a new class of glucose-responsive polymer nanogels that could one day negate the need for diabetes patients to constantly monitor their blood glucose levels and inject themselves with insulin.
Chemistry World May 7, 2009 Phillip Broadwith	Polymers release insulin in response to glucose trigger Chinese researchers have developed polymer nanoparticles that can release insulin in response to changes in glucose concentration, creating a potential treatment for diabetes.
American Family Physician May 1, 2005	Diabetic Ketoacidosis: What It Is and How to Prevent It An informative patient hand-out on the condition, its causes, triggers, prevention and instructions on what do if the conditions presents.
AskMen.com Alex Santoso	What You Should Know About Diabetes Not many men understand what diabetes is, why it's very bad for them (it is one of the leading causes of impotence), what they can do to avoid getting it or how to treat it.
American Family Physician January 1, 2003 Jennifer B. Marks	Perioperative Management of Diabetes Diabetic patients who require surgery present special challenges in perioperative management. Special attention must be paid to prevention and treatment of metabolic derangements.
American Family Physician March 15, 2001 Goutham Rao	Insulin Resistance Syndrome Insulin resistance can be linked to diabetes, hypertension, dyslipidemia, cardiovascular disease and other abnormalities. Because resistance usually develops long before these diseases appear, identifying and treating insulin-resistant patients has potentially great preventive value...
Nurse Practitioner May 2011 Stacey A. Seggelke	Hitting the target for inpatient glycemic management An understanding of glycemic treatment options for hospitalized patients is essential for good patient outcomes.
Chemistry World February 2, 2015 Megan Tyler	Shock tactics for drug delivery Scientists in India have developed a shock wave-based drug delivery system that could be used to administer insulin in diabetic patients and reduce the need for painful injections.
American Family Physician September 15, 2006 Havas & Donner	Tight Control of Type 1 Diabetes: Recommendations for Patients Physicians play an important role in helping type 1 diabetes patients make essential lifestyle changes to help reduce the risk of microvascular and macrovascular complications.
Nursing Management January 2012 Lawrence et al.	Type 2 Diabetes: Growing to Epic Proportions Affecting all age groups and all aspects of a person's life, diabetes is a major public health issue worldwide, requiring lifelong behavioral and lifestyle changes and support.
Managed Care December 2003 Thomas Morrow	Can Amylin Analogue Lead To Better Diabetes Control? Maintaining tight glucose control is difficult to accomplish, but adding amylin to the mix may be the answer.
American Family Physician August 1, 2004 Mayfield & White	Insulin Therapy for Type 2 Diabetes: Rescue, Augmentation, and Replacement of Beta-Cell Function New insulin preparations and a better understanding of insulin physiology provide more options for family physicians attempting to effectively tailor insulin therapy to the needs of individual patients.
American Family Physician May 1, 2001	Treatment Options for Type 2 Diabetes -- What's Available? What are the different steps in managing my diabetes? What are the different types of medicines used to treat type 2 diabetes and how do they work?
AskMen.com April 29, 2001 Joshua Levine	Do You Have Diabetes? Diabetes is not contagious; people cannot "catch" it from one another. However, certain factors can increase one's risk of developing the disease...
Nursing November 2009 Christine Kessler	Glycemic control in the hospital: How tight should it be? Based on recent studies, the answer to that question remains controversial. This article will explore this issue and present current best practices for caring for a patient in the hospital who has diabetes or hyperglycemia.
American Family Physician July 15, 2006 Jennifer D. Goldman-Levine	Insulin Detemir (Levemir) for Diabetes Mellitus Insulin detemir is suitable as basal insulin in a basal-bolus regimen. In limited research, it has been shown to cause slightly fewer episodes of minor hypoglycemia and no weight gain in patients with type 1 and 2 diabetes, which is a benefit that must be balanced against its higher price.
Managed Care July 2004 Udaya M. Kabadi	Cost-Effective Management of Hyperglycemia in Patients with Type 2 Diabetes Using Oral Agents Sulfonylureas are cost-effective and also may be the only oral agents that inhibit processes inducing hyperglycemia by improving insulin secretion and insulin resistance. New long-acting agents hold even greater promise.
Pharmaceutical Executive October 1, 2005	Changing Diabetes An interview with Novo Nordisk's president of U.S. operations Martin Soeters on how a nation that leads the world in diabetes research does such a poor job of treating it. Here, he offers some solutions.
Chemistry World February 20, 2014 Laura Howes	Brent Sumerlin: Searching for a sweet response Brent Sumerlin is professor of chemistry at the University of Florida in Gainesville, US. His research concerns the identification, synthesis, and characterization of smart polymers for drug delivery.
Pharmaceutical Executive February 1, 2007 Iaquinto & Palmisano	Medical Education: A Platform for Success By pumping the science behind a brand, pharmaceutical companies can garner early loyalist - before a drug even hits the market.
The Motley Fool July 17, 2006 Stephen D. Simpson	Medtronic's Evolutionary Revolution Step by step, Medtronic may change how diabetes is treated.
The Motley Fool July 27, 2007 Rich Duprey	Sniffing Out Bentley's New Patent To succeed in insulin therapy, the generic drugmaker must overcome patent expiration. Investors, take note.
Managed Care May 2006 Fadia T. Shaya & Deshpande	New Treatment Approaches To Diabetes The goal of diabetes management is maintaining glycemic control while targeting quality of life improvements.
Chemistry World April 8, 2014 Sarah Kenwright	Olive oil may offer diabetes protection Spanish scientists say increasing the amount of olive oil in your diet could reduce your risk of developing metabolic syndrome and type 2 diabetes.
The Motley Fool September 9, 2008 Brian Orelli	Drug Duo Combines Its Way Toward an Approval Bristol-Myers and AstraZeneca are trying to get their diabetes drug approved as a combination treatment.
American Family Physician November 1, 2003 Turok et al.	Management of Gestational Diabetes Mellitus Although the disorder affects approximately 2.5 percent of pregnant women and has been the subject of extensive research, its diagnosis and management continue to be debated.
Managed Care October 2005 Thomas Morrow	Incretin Hormones Poised For Better Control of Diabetes Enhanced management continues due to a greater understanding of the intricate glucose balance and the shortfalls of existing medications.
Chemistry World September 18, 2013 Sonja Hampel	Beetle feet inspire drug delivery patches A drug delivery plaster mimicking the wet adhesion of beetle feet has been developed by scientists in Taiwan.
American Family Physician November 1, 2000	Diabetes: Flexible Insulin Regimens for People with Type 1 Diabetes What is insulin?... How do I use insulin?... What is a flexible insulin regimen?... When should I take insulin?...
The Motley Fool December 3, 2010 Brian Orelli	Merck Smartens Up The acquisition of SmartCells looks like an intelligent move.
BusinessWeek December 22, 2003 Arlene Weintraub	Big Pharma Looks Beyond Insulin Researchers may be on the verge of major new treatments for diabetes and obesity.
Chemistry World May 17, 2009 Simon Hadlington	Non-stick approach to regular polymer vesicles UK researchers have devised a new method for making polymer vesicles
Scientific American December 12, 2005 Philip E. Ross	Grow Your Own Getting a diabetic pancreas to regrow its islets -- growth factors could restore beta cells lost in type 1 diabetes.
The Motley Fool October 27, 2005 Stephen D. Simpson	What's New With Novo? Novo Nordisk is a good play on diabetes, but will new drugs reduce the need for insulin? Investors, take note.
Managed Care May 2007 Rachel M. Renshaw	Keys to Diabetes Control? Patience, Persistence, and Perseverance Careful attention to a comprehensive treatment plan could forestall or prevent the need to add drugs and costs to a patient's regimen.
The Motley Fool August 21, 2007 Brian Orelli	Sweet Phase 3 Data Although diabetes drugs have come under fire lately, insulin maker Novo Nordisk is moving full steam ahead with its newest drug to help fight type 2 diabetes.
Managed Care November 2005 Thomas Morrow	This Nutritional Supplement Might be an Inexpensive Way to Improve Glycemic Control for the 18 Million Americans with Diabetes The review of the existing literature suggests that chromium picolinate with biotin offers people with diabetes hope for the future at a price that is less than what would be their copayment for a normal monthly generic drug.
Pharmaceutical Executive August 1, 2005	Making Drugs Smarter An interview with Nicholas Peppas on how the world of drug delivery -- at least at its cutting edges -- has begun to converge with diagnostics, tissue design, and materials science in ways that promise to transform some areas of medicine.
American Family Physician May 1, 2005 David E. Trachtenbarg	Diabetic Ketoacidosis Initial evaluation of patients with DKA includes diagnosis and treatment of precipitating factors. Education to prevent recurrence should be offered to all patients, including how to manage sick days and when to call a physician.
IEEE Spectrum January 2011 Sandra Upson	Bionic Pancreas Artificial organ could improve control over diabetes
Food Processing August 2013 Mark Anthony	The Condemnation of Carbohydrates: A Food Manufacturers Guide to Understanding Diabetes The commonly held notion that sugar intake equals diabetes is a kind of unofficial dogma. But like many dogmas, this one falls apart upon closer examination.
Chemistry World November 8, 2012 Michael Parkin	Nasal gel alternative to insulin injection Scientists has developed a novel insulin delivery system for nasal administration. The study aims to provide an alternative to regular injections through the delivery of insulin via the nasal membrane in the form of a hydrogel.
HHMI Bulletin Fall 2012 Sarah C. P. Williams	The Fat You Can't See Without the liver acting as a filter and energy producer, a person can't survive, and no artificial organ can perform all of its duties. But in one in three Americans -- and similar numbers in other developed nations -- the liver has lost its luster.
The Motley Fool August 12, 2005 Stephen D. Simpson	Novo Nordisk Perks Up This leading insulin company rebounds from a sluggish first quarter. For investors willing to buy and hold a stock for years, Novo Nordisk could still be an interesting play on a serious and growing disease market.
American Family Physician April 15, 2004 Rao, Disraeli & Mcgregor	Impaired Glucose Tolerance and Impaired Fasting Glucose Impaired glucose tolerance and impaired fasting glucose form an intermediate stage in the natural history of diabetes mellitus.
Science News April 14, 2007 Janet Raloff	Cinnamon and Diabetes--Disease Type Appears to Matter Many teens with type 1 diabetes need help maintaining tight control of their blood sugar. Cinnamon isn't the answer, a new study finds, even though the spice appears to help moderate blood sugar in persons with type 2 diabetes.
Managed Care April 2004 Thomas Morrow	Transdermal Patches Are More Than Skin Deep After modest beginnings, transdermal patches are now taking advantage of nanotechnology and other novel techniques to improve drug delivery.
Managed Care April 2005	Diabetes Costs Rise, But so Does Adherence A typical health plan can expect endocrine and diabetes agents to amount to 6% to 8% of total utilization costs, with spending on these agents to increase between 11% and 15% 2005.
BusinessWeek April 30, 2010 Drew Armstrong	The Lobbying for Death by Diabetes How a health-reform provision may help spur sales of insulin.
Technology Research News December 3, 2003	Microneedles give painless shots The smaller the hypodermic needle, the less it hurts when it pierces skin. Researchers demonstrated that an array of 400 microneedles can be used to pierce human skin, and successfully used a similar micro array to deliver insulin to diabetic rats.